Cytokinetics Drug Patent Portfolio
Cytokinetics owns 1 orange book drug protected by 2 US patents Given below is the list of Cytokinetics's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US12370179 | 15 Jul, 2042 | Active | |
| US10836755 | Cardiac Sarcomere Inhibitors | 18 Jan, 2039 | Active |
Latest Legal Activities on Cytokinetics's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Cytokinetics.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Recordation of Patent Grant Mailed | 05 Aug, 2025 | US12370179 |
| Email Notification | 29 Jul, 2025 | US12370179 |
| Recordation of Patent eGrant | 29 Jul, 2025 | US12370179 |
| Mail Patent eGrant Notification | 29 Jul, 2025 | US12370179 |
| Patent Issue Date Used in PTA Calculation | 29 Jul, 2025 | US12370179 |
| Patent eGrant Notification | 29 Jul, 2025 | US12370179 |
| Email Notification | 21 Jul, 2025 | US12370179 |
| Issue Notification Mailed | 16 Jul, 2025 | US12370179 |
| Dispatch to FDC | 08 Jul, 2025 | US12370179 |
| Application Is Considered Ready for Issue | 08 Jul, 2025 | US12370179 |
| Issue Fee Payment Received | 01 Jul, 2025 | US12370179 |
| Issue Fee Payment Verified | 01 Jul, 2025 | US12370179 |
| Mail Notice of Allowance | 17 Jun, 2025 | US12370179 |
| Email Notification | 17 Jun, 2025 | US12370179 |
| Notice of Allowance Data Verification Completed | 16 Jun, 2025 | US12370179 |
Cytokinetics's Family Patents
Cytokinetics Drug List
Given below is the complete list of Cytokinetics's drugs and the patents protecting them.
1. Myqorzo
Myqorzo is protected by 2 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US12370179 |
15 Jul, 2042
(16 years from now)
| Active | |
| US10836755 | Cardiac Sarcomere Inhibitors |
18 Jan, 2039
(12 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Myqorzo's drug page